Coalition pour de meilleurs médicaments / Best Medicines Coalition
Enregistrement :
20
de
54
(2020-03-23
à
2020-03-23)
Politique ou Programme
Ensure patient organizations are consulted during the proposed creation of the Canadian Drug Agency as outlined in Budget 2019.
Provide feedback on Budget 2019's proposal for a national strategy for high-cost drugs for rare diseases.
Provide feedback on the Government of Canada's response to COVID-19 to address the potential exacerbation of drug shortages.
Politique ou Programme, Règlement
Meet with federal officials to discuss Canada's response to the proposed bulk importation of medications from Canada to the United States.
Proposition législative, Projet de loi ou résolution
Provide feedback on Bill C-213, the Canada Pharmacare Act.
Share patient groups perspectives on national pharmacare proposals (follow-up from the Health Committee's report and the ongoing work of the Advisory Council on the Implementation of National Pharmacare)
Règlement
Feedback on "Fit for Purpose: Findings and Recommendations of the External Review of the Pan-Canadian Health Organizations - Summary Report"
Request to delay implementation of the federal PMPRB regulations in light of the COVID-19 pandemic allowing all stakeholders to focus efforts on dealing with the public health emergency.
Share patient groups perspectives on drug pricing issues, specifically the Patented Medicine Prices Review Board's proposed regulations.